Chloe Ramirez
The CDC, or Centers for Disease Control and Prevention, is the US's national health protection agency. The FDA, or Food and Drug Administration, is tasked with approving new vaccines, while the CDC's advisory committee on immunization practices must issue recommendations for who should get the vaccine. This guidance is important for pharmacists and insurance companies. The CDC has been at the centre of controversy in 2025, with the firing of CDC Director Susan Monarez after she refused to approve vaccine policies.
| Characteristics | Values |
|---|---|
| Who approves new vaccines? | The Food and Drug Administration (FDA) |
| Who decides which vaccines are required for school attendance? | State legislatures |
| Who is the current CDC Director? | Susan Monarez (recently fired) |
| Who fired Susan Monarez? | The White House |
| Why was Susan Monarez fired? | She refused to approve vaccine policies preferred by Health and Human Services Secretary Robert F. Kennedy Jr. |
| Who is the Health and Human Services Secretary? | Robert F. Kennedy Jr. |
| What is Kennedy's stance on vaccines? | He is a longtime anti-vaccine activist |
| What is the CDC's role in vaccine recommendations? | The CDC's advisory committee on immunization practices meets to discuss recommendations for who should get the shot, providing guidance to pharmacists. |
| What is the role of insurance companies? | Insurance companies are only required to pay for shots if they have been recommended by the CDC. |
| What are the recent changes in CDC leadership? | Kennedy dissolved the CDC's long-standing vaccine advisory committee and replaced them with members who have criticized vaccines and spread misinformation. |
| What is the impact of the CDC leadership changes? | There is bipartisan fury, with senators demanding a probe and rejecting vaccine guidance as illegitimate. |
| What is the role of the FDA in approving COVID-19 vaccines? | The FDA approves updated COVID-19 vaccines with restrictions on eligibility, such as age and health conditions. |
| What are the restrictions on COVID-19 vaccine eligibility? | Eligibility is limited to high-risk individuals, including those over 65 and those with specific underlying conditions. |
Explore related products
What You'll Learn
The CDC's advisory committee on immunization practices
The Advisory Committee on Immunization Practices (ACIP) is a committee within the United States Centers for Disease Control and Prevention (CDC). It was established in March 1964 by the US Surgeon General to assist in preventing and controlling communicable diseases. The committee is made up of medical and public health experts who develop recommendations on the use of vaccines in the civilian population of the United States. ACIP statements are official federal recommendations for using vaccines and immune globulins in the US and are published by the CDC.
The ACIP provides advice and guidance to the Secretary, HHS, the Assistant Secretary for Health, and the Director of the CDC on the most appropriate selection of vaccines and related agents for effective control of vaccine-preventable diseases in the civilian population. The committee provides advice for the control of diseases for which a vaccine is licensed in the US, covering the appropriate use of the vaccine and making recommendations for the administration of immune globulin preparations and/or antimicrobial therapies.
The ACIP develops written recommendations for the routine administration of vaccines to pediatric and adult populations, along with vaccination schedules regarding appropriate timing, dosage, and contraindications of vaccines. The recommendations are then forwarded to the CDC Director for approval. Once approved, the recommendations appear in the CDC's Morbidity and Mortality Weekly Report and represent the official CDC recommendations for immunizations in the US.
In June 2025, the Secretary of Health and Human Services, Robert F. Kennedy Jr., fired all 17 ACIP members and replaced them with members who are either anti-vaccine activists or who lack expertise in vaccines. Kennedy, a longtime anti-vaccine activist, claimed that he was restoring the public's trust in the CDC and vaccine science by eliminating bias and conflicts of interest. However, this decision was met with criticism, with nine former directors of the CDC condemning Kennedy's leadership in an op-ed.
RCCP Vaccine: Does It Cover Feline Herpes?
You may want to see also
Explore related products
The CDC's role in vaccine availability
The CDC plays a crucial role in vaccine availability and policy in the United States. While the Food and Drug Administration (FDA) is responsible for approving new vaccines, the CDC has multiple key functions in vaccine availability.
Firstly, the CDC provides recommendations on who should receive specific vaccines. These recommendations are made by the CDC's advisory committee on immunization practices, known as the ACIP. The ACIP's guidance helps pharmacists and healthcare providers determine who should receive a particular vaccine. For example, the CDC's recommendations can influence which vaccines are required for school attendance and whether COVID-19 vaccines are advised for specific groups, such as healthy pregnant women or children.
Secondly, the CDC's recommendations can impact insurance coverage for vaccines. Insurance companies often base their decisions on whether to cover a vaccine on the CDC's recommendations. If the CDC recommends a vaccine, insurance providers are more likely to include it in their coverage.
Thirdly, the CDC's recommendations can affect the availability of vaccines in certain settings, particularly pharmacies. In some states, pharmacists are authorised to administer vaccines based on the CDC's recommendations. Until the CDC's advisory committee issues its guidance, pharmacists in these states may need a prescription to provide the vaccine or may be unable to offer it at all.
Vaccination Status: What Does "Fully Vaccinated" Really Mean?
You may want to see also
Explore related products
The CDC's influence on insurance coverage
Firstly, the CDC's Advisory Committee on Immunization Practices (ACIP) is a key player in this process. ACIP is a federal advisory committee that provides advice and guidance to the CDC Director on vaccine usage for the public. The CDC Director reviews and adopts ACIP's recommendations, which are then published as official guidelines. These recommendations serve as a basis for insurance coverage decisions. If the CDC narrows or removes a vaccine recommendation, such as in the case of COVID-19 for healthy children and pregnant women, insurers may no longer be required to provide no-cost coverage for those populations.
Secondly, the CDC's role in vaccine approval and policy-making also influences insurance coverage. The CDC, in collaboration with the Food and Drug Administration (FDA), provides guidance and recommendations on vaccine usage and eligibility. For example, the CDC's advisory committee on immunization practices meets to discuss recommendations for specific vaccines, such as COVID-19, and provides guidance to pharmacists and healthcare providers nationwide. The CDC's approval and recommendations can impact insurance coverage policies, as insurers may follow these guidelines to determine coverage eligibility.
Additionally, the CDC's influence extends to state-level vaccine policies and insurance coverage. While state legislatures typically determine which vaccines are required for school attendance, the CDC's recommendations can shape these decisions. The CDC provides scientific expertise and data to inform state-level vaccine policies, and states may choose to align their insurance coverage with CDC guidelines.
Moreover, the CDC's role in vaccine safety and effectiveness monitoring is also crucial. The CDC conducts research, surveillance, and analysis to assess vaccine safety and effectiveness. This information is used to update vaccine recommendations and guidelines, which in turn, can influence insurance coverage decisions. Insurers may consider the CDC's safety and effectiveness data when determining coverage for specific vaccines.
It is important to note that the CDC's influence on insurance coverage is not unilateral. Other factors, such as state regulations, insurance company policies, and federal laws, also play a significant role in determining insurance coverage for vaccines. The interplay between the CDC's recommendations and these external factors shapes the landscape of vaccine insurance coverage in the United States.
Immunization Coalitions: Power of Collaboration
You may want to see also
Explore related products
The CDC's vaccine recommendation panel
The new panel is expected to meet and discuss vaccine recommendations, causing concern among senators that the committee may vote to change advice on routine childhood immunisations. The panel's advice will impact vaccine coverage decisions by insurers and could potentially limit access to vaccines for some Americans, particularly healthy adults and children.
The CDC's advisory committee on immunisation practices plays a crucial role in providing guidance to pharmacists and healthcare professionals across the country. The committee's recommendations carry significant weight and can influence state-level decisions on vaccine requirements for school attendance.
The recent turmoil at the CDC and the firing of Monarez, along with the resignation of several senior officials, have sparked bipartisan fury. Senators from both parties have demanded a probe into the matter and rejected the new vaccine guidance as illegitimate.
Pneumonia Vaccine for Seniors: Free or Fee?
You may want to see also
Explore related products
The CDC's stance on COVID-19 vaccines for pregnant women
In 2025, the CDC's stance on COVID-19 vaccines for pregnant women has been a subject of debate and controversy. Initially, the CDC recommended the COVID-19 vaccine for all Americans aged 6 months and older, including pregnant women. However, in late May, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the CDC would no longer recommend COVID-19 vaccines for healthy children and healthy pregnant women.
Following this announcement, the CDC updated its guidance to a "'shared clinical decision-making' model, leaving the vaccination decision between patients or parents and their doctors. This change caused concern among some, with reports of women facing difficulties in accessing COVID-19 vaccines during pregnancy. Despite the lack of a direct recommendation from the CDC, pregnancy and recent pregnancy are still considered conditions that increase the risk of severe COVID-19. The American College of Obstetricians and Gynecologists has reaffirmed its support for COVID-19 vaccination during pregnancy.
The controversy surrounding the CDC's stance on vaccine recommendations led to turmoil within the organization. CDC Director Susan Monarez, along with several senior officials, resigned or were fired due to their disagreement with Kennedy's views and pressure to approve certain vaccine policies. Senators from both Republican and Democratic parties demanded a probe into the CDC's vaccine guidance, expressing concern for the well-being of pregnant people and children.
While the CDC's advisory committee on immunization practices works to provide guidance to pharmacists and healthcare providers, the ultimate decision regarding vaccine recommendations during pregnancy is left to individual healthcare providers and their patients. This "shared decision-making" approach considers the unique circumstances and risks faced by each pregnant individual.
It is important to note that the CDC's stance on COVID-19 vaccines for pregnant women may continue to evolve as new scientific evidence and research emerge. Pregnant women are advised to consult their healthcare providers to discuss the benefits and risks of vaccination and make informed decisions based on their specific circumstances.
Diphtheria, Tetanus, and Pertussis: One Vaccine, Three Diseases
You may want to see also
Frequently asked questions
No, the CDC does not approve vaccines. The Food and Drug Administration (FDA) is responsible for approving new vaccines. The CDC does, however, provide recommendations on who should receive the vaccines.
The CDC's advisory committee on immunization practices, the ACIP, makes recommendations on who should receive the vaccine. These recommendations are then accepted by the CDC director. The ACIP's guidance is crucial as it allows pharmacists in certain states to administer the vaccines.
There was controversy surrounding the 2025 COVID-19 vaccine approval. The CDC Director, Susan Monarez, was fired by the White House for refusing to approve vaccine policies preferred by Health and Human Services Secretary Robert F. Kennedy Jr. Kennedy, a known anti-vaccine activist, denied pressuring Monarez to approve vaccine recommendations.
